{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:56:34Z","timestamp":1783356994311,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"BASF"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.yrtph.2020.104713","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:35:36Z","timestamp":1592393736000},"page":"104713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines"],"prefix":"10.1016","volume":"115","author":[{"given":"Susanne N.","family":"Kolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Landsiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Natsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2020.104713_bib2","doi-asserted-by":"crossref","first-page":"104477","DOI":"10.1016\/j.yrtph.2019.104477","article-title":"Applying non-animal strategies for assessing skin sensitisation report from an EPAA\/cefic-LRI\/IFRA Europe cross sector workshop, ECHA helsinki, February 7th and 8th 2019","volume":"109","author":"Basketter","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2020.104713_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermatitis"},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.yrtph.2012.05.013","article-title":"Putting the parts together: combining in vitro methods to test for skin sensitizing potentials","volume":"63","author":"Bauch","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104713_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2019.03.039","article-title":"Workshop on the validation and regulatory acceptance of innovative 3R approaches in regulatory toxicology - evolution versus revolution","volume":"59","author":"Burgdorf","year":"2019","journal-title":"Toxicol. Vitro"},{"issue":"2","key":"10.1016\/j.yrtph.2020.104713_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00204-017-2097-4","article-title":"Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods","volume":"92","author":"Casati","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2020.104713_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.yrtph.2018.03.003","article-title":"International regulatory requirements for skin sensitization testing","volume":"95","author":"Daniel","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104713_bib9","series-title":"Practical Guide How to Use and Report (Q)SAR","year":"2016"},{"key":"10.1016\/j.yrtph.2020.104713_bib10","series-title":"Guidance on Information Requirements and Chemical Safety Assessment Chapter R.7a: Endpoint Specific Guidance","year":"2017"},{"key":"10.1016\/j.yrtph.2020.104713_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.taap.2010.03.009","article-title":"Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro","volume":"245","author":"Emter","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2020.104713_bib12","series-title":"Interim Science Policy: Use of Alternative Approaches for Skin Sensitization as a Replacement for Laboratory Animal Testing","year":"2018"},{"issue":"4","key":"10.1016\/j.yrtph.2020.104713_bib13","first-page":"400","article-title":"The usefulness of integrated strategy approaches in replacing animal experimentation","volume":"55","author":"Eskes","year":"2019","journal-title":"Ann. Istituto Super. Sanita"},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/rtph.2001.1498","article-title":"ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods","volume":"34","author":"Haneke","year":"2001","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2020.104713_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup\/>","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2020.104713_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches (*)","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"4","key":"10.1016\/j.yrtph.2020.104713_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/DER.0000000000000393","article-title":"Patch testing to propylene glycol: the mayo clinic experience","volume":"29","author":"Lalla","year":"2018","journal-title":"Dermatitis"},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib19","first-page":"435","article-title":"The impact of precision uncertainty on predictive accuracy metrics of non-animal testing methods","volume":"36","author":"Leontaridou","year":"2019","journal-title":"ALTEX"},{"issue":"7","key":"10.1016\/j.yrtph.2020.104713_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.tiv.2012.07.001","article-title":"Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency","volume":"26","author":"Nukada","year":"2012","journal-title":"Toxicol. Vitro"},{"issue":"2","key":"10.1016\/j.yrtph.2020.104713_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tiv.2012.11.006","article-title":"Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals","volume":"27","author":"Nukada","year":"2013","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2020.104713_bib22","series-title":"Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models","year":"2007"},{"key":"10.1016\/j.yrtph.2020.104713_bib23","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","year":"2012"},{"key":"10.1016\/j.yrtph.2020.104713_bib24","series-title":"Guidance Document on the Reporting of Defined Approaches and Individual Information Sources to Be Used within Integrated Approaches to Testing and Assessment (IATA) for Skin Sensitisation","year":"2016"},{"key":"10.1016\/j.yrtph.2020.104713_bib25","series-title":"Guidance Document on the Reporting of Defined Approaches to Be Used within Integrated Approaches to Testing and Assessment","year":"2016"},{"key":"10.1016\/j.yrtph.2020.104713_bib26","series-title":"Vitro Skin Sensitisation","article-title":"Test No. 442D","year":"2018"},{"key":"10.1016\/j.yrtph.2020.104713_bib27","series-title":"Vitro Skin Sensitisation","article-title":"Test No. 442E","author":"OECD","year":"2018"},{"key":"10.1016\/j.yrtph.2020.104713_bib28","series-title":"Draft Guideline for Defined Approaches for Skin Sensitisation","year":"2019"},{"key":"10.1016\/j.yrtph.2020.104713_bib29","series-title":"Draft Supporting Document for Defined Approaches for Skin Sensitisation","year":"2019"},{"key":"10.1016\/j.yrtph.2020.104713_bib30","series-title":"Chemico Skin Sensitisation","article-title":"Test No. 442C","year":"2019"},{"key":"10.1016\/j.yrtph.2020.104713_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tiv.2018.02.018","article-title":"Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies","volume":"50","author":"Piersma","year":"2018","journal-title":"Toxicol. Vitro"},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/026119291604400311","article-title":"Local tolerance testing under REACH: accepted non-animal methods are not on equal footing with animal tests","volume":"44","author":"Sauer","year":"2016","journal-title":"Altern. Lab. Anim."},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0536.2011.01939.x","article-title":"Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products","volume":"65","author":"Schnuch","year":"2011","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.yrtph.2020.104713_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ffj.3241","article-title":"Risk of sensitization to fragrances estimated on the basis of patch test data and exposure, according to volume used and a sample of 5451 cosmetic products","volume":"30","author":"Schnuch","year":"2015","journal-title":"Flavour Fragrance J."},{"issue":"2","key":"10.1016\/j.yrtph.2020.104713_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00204-018-2341-6","article-title":"Skin sensitization testing needs and data uses by US regulatory and research agencies","volume":"93","author":"Strickland","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"11","key":"10.1016\/j.yrtph.2020.104713_bib36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jat.3127","article-title":"Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals","volume":"35","author":"Takenouchi","year":"2015","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2020.104713_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14573\/altex.1803011","article-title":"The US Federal Tox21 Program: a strategic and operational plan for continued leadership","volume":"35","author":"Thomas","year":"2018","journal-title":"ALTEX"},{"issue":"2","key":"10.1016\/j.yrtph.2020.104713_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.yrtph.2020.104713_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tiv.2017.08.015","article-title":"Prediction of skin sensitization potency sub-categories using peptide reactivity data","volume":"45","author":"Wareing","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2020.104713_bib40","series-title":"EURL ECVAM Status Report on the Development, Validation and Regulatory Acceptance of Alternative Methods and Approaches (2017)","author":"Zuang","year":"2017"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020301392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230020301392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:31:02Z","timestamp":1759494662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230020301392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"alternative-id":["S0273230020301392"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104713","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2020.104713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104713"}}